Paolo Calabrò

Showing 1-3 of 3 articles

Coronary interventions

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal

Pelliccia F, Niccoli G, Gragnano F, Limongelli G, Moscarella E, Andò G, Esposito A, Stabile E, Ussia G, Tarantini G, Gimeno JR, Elliott P, Calabrò P

August 29, 2019 | 10.4244/EIJ-D-18-00959

One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry)

Ielasi A, Cortese B, Moscarella E, Loi B, Tarantini G, Varricchio A, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Pietro Mazzarotto P, Tespili M, Orrego P, Corrado D, Steffenino G

August 3, 2018 | 10.4244/EIJ-D-17-00443

Coronary interventions

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

De Servi S, Crimi G, Calabrò P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo D, Palmerini T

June 20, 2016 | 10.4244/EIJV12I3A51

1

Latest news

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Defining procedural MI - does it matter (spoiler alert - it does!)

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke